Cargando…

COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database

Detalles Bibliográficos
Autores principales:	Villa-Zapata, Lorenzo, Gomez-Lumbreras, Ainhoa, Lee, Yeseul, Tan, Malinda S., Malone, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asociación Española de Pediatría. Published by Elsevier España, S.L.U. 2023
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009742/ https://www.ncbi.nlm.nih.gov/pubmed/36922249 http://dx.doi.org/10.1016/j.anpede.2022.10.011

Ejemplares similares

Eventos adversos en vacunas COVID-19 en una población de 5 a 17 años: estudio de la base de datos VAERS
por: Villa-Zapata, Lorenzo, et al.
Publicado: (2023)

EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5–17 Years: A Study of Reports from the VAERS Database
por: Lee, Y, et al.
Publicado: (2022)

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
por: Tan, Malinda S., et al.
Publicado: (2022)

Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
por: Geier, David A., et al.
Publicado: (2016)

Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics’ impact
por: Almadani, Ohoud A., et al.
Publicado: (2022)

Adverse event detection by integrating twitter data and VAERS
por: Wang, Junxiang, et al.
Publicado: (2018)

Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports
por: Riad, Abanoub, et al.
Publicado: (2022)

Ontology-based time information representation of vaccine adverse events in VAERS for temporal analysis
por: Tao, Cui, et al.
Publicado: (2012)

Identification of sex-associated network patterns in Vaccine-Adverse Event Association Network in VAERS
por: Zhang, Yuji, et al.
Publicado: (2015)

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
por: Geier, David A., et al.
Publicado: (2012)

Linked vaccine adverse event data from VAERS for biomedical data analysis and longitudinal studies
por: Tao, Cui, et al.
Publicado: (2014)

Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports
por: Guo, Wenxin, et al.
Publicado: (2022)

COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
por: Zhang, Bing, et al.
Publicado: (2022)

Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database
por: Falotico, Julianne M., et al.
Publicado: (2022)

Vocal Fold Paralysis Following COVID-19 Vaccination: Query of VAERS Database
por: Hamdi, Osama A., et al.
Publicado: (2022)

WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
por: Rose, Jessica, et al.
Publicado: (2021)

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021
por: Moro, Pedro L., et al.
Publicado: (2022)

Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data
por: Tao, Cui, et al.
Publicado: (2015)

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management
por: Hansten, Philip D., et al.
Publicado: (2022)

EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports
por: Alqahtani, Z, et al.
Publicado: (2022)

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)
por: Welsh, Kerry J., et al.
Publicado: (2021)

Vaccines and sudden infant death: An analysis of the VAERS database 1990–2019 and review of the medical literature
por: Miller, Neil Z.
Publicado: (2021)

Glaucoma Cases Following SARS-CoV-2 Vaccination: A VAERS Database Analysis
por: Singh, Rohan Bir, et al.
Publicado: (2022)

Reports of Guillain–Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database
por: Chalela, Julio A., et al.
Publicado: (2023)

Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database
por: Santi Laurini, Greta, et al.
Publicado: (2023)

Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990–2010
por: Goldman, GS, et al.
Publicado: (2012)

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015
por: Moro, Pedro L., et al.
Publicado: (2016)

EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS)
por: Alahmari, AK, et al.
Publicado: (2022)

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)
por: Kravchenko, Olga V, et al.
Publicado: (2022)

Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years
por: Kim, Seontae, et al.
Publicado: (2022)

Trivalent influenza vaccine adverse symptoms analysis based on MedDRA terminology using VAERS data in 2011
por: Du, Jingcheng, et al.
Publicado: (2016)

CERN kan være noget for dig
por: Kristensen, S T, et al.
Publicado: (1996)

Fysikundervisning som det burde være
Publicado: (2008)

Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis
por: Santi Laurini, Greta, et al.
Publicado: (2023)

Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis
por: Xie, Jiangan, et al.
Publicado: (2016)

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017
por: Arana, Jorge, et al.
Publicado: (2018)

Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015
por: Haber, Penina, et al.
Publicado: (2016)

Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”
por: Cohen, Carine, et al.
Publicado: (2018)

Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022
por: Moro, Pedro L., et al.
Publicado: (2023)

Are the VAERS-included reactions following the human papillomavirus immunization correlated to the number of vaccine doses?
por: Poddighe, Dimitri
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oskic8ldcvbpqbau162b0gddr4